Oxytocin Nasal Spray For Sale
High-purity neuropeptides are critical reagents for investigating central nervous system signaling pathways, neuroendocrine feedback, and behavioral modulation in laboratory models. PX1 Research provides laboratory-grade oxytocin nasal spray formulations manufactured under strict analytical quality standards for in vitro and preclinical research applications. Every lot undergoes rigorous testing to guarantee sequence integrity, accurate peptide concentration, and minimal endotoxin burden.
Quick answer
High-purity neuropeptides are critical reagents for investigating central nervous system signaling pathways, neuroendocrine feedback, and behavioral modulation in laboratory models. PX1 Research provides laboratory-grade oxytocin nasal spray formulations manufactured under strict analytical quality standards for in vitro and preclinical research applications. Every lot undergoes rigorous testing to guarantee sequence integrity, accurate peptide concentration, and minimal endotoxin burden.
Key takeaways
- Research-grade [oxytocin](/research-peptides/oxytocin) nasal spray formulations for laboratory investigation are available from qualified domestic suppliers like PX1 Research.
- [Oxytocin](/research-peptides/oxytocin) is a cyclic nonapeptide neuropeptide with the amino acid sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, featuring an intramolecular disulfide bridge between the cysteine residues at positions 1 and 6.
- Intranasal administration has emerged as a preferred non-invasive route for delivering neuropeptides to the central nervous system in preclinical rodent and non-human primate models.
- In vitro data and rodent models demonstrate that central [oxytocin](/research-peptides/oxytocin) signaling modulates diverse neurobehavioral and neuroendocrine processes.
Sourcing High-Purity Oxytocin Nasal Spray Formulations for Research
Research-grade oxytocin nasal spray formulations for laboratory investigation are available from qualified domestic suppliers like PX1 Research. Formulated strictly for in vitro assays and preclinical intranasal administration models, this nonapeptide solution undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis to confirm peptide sequence purity above 99%, accompanied by batch-specific endotoxin quantification and lot traceability.
When procuring neuropeptides for laboratory investigation, academic institutions and independent research facilities require absolute consistency in sequence purity and concentration. Substandard reagents containing residual trifluoroacetic acid (TFA), uncoupled amino acid impurities, or microbial endotoxins can artifactually alter cell culture viability, receptor binding kinetics, and behavioral metrics in animal models. Obtaining oxytocin nasal spray from a vendor committed to rigorous quality assurance ensures that experimental outcomes reflect true biological phenomena rather than reagent contamination.
Molecular Structure and Receptor Binding Profile of Oxytocin
Oxytocin is a cyclic nonapeptide neuropeptide with the amino acid sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, featuring an intramolecular disulfide bridge between the cysteine residues at positions 1 and 6. This molecular architecture creates a stable ring structure that is critical for selective target binding. Biological activity is primarily mediated via the oxytocin receptor (OXTR), a Class A Rhodopsin-like G-protein coupled receptor (GPCR) predominantly coupled to the Gq/11 signaling cascade.
Upon receptor activation in cellular models, the Gq/11 pathway triggers phospholipase C-beta (PLC-β) activation, driving the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 stimulates rapid mobilization of intracellular calcium ions (Ca2+) from the endoplasmic reticulum, while DAG activates protein kinase C (PKC). To explore the full mechanistic profile of this nonapeptide, researchers frequently review the broader literature on oxytocin neuromodulation pathways to evaluate downstream transcriptomic and electrophysiological responses.
Intranasal Delivery Mechanisms in Preclinical Models
Intranasal administration has emerged as a preferred non-invasive route for delivering neuropeptides to the central nervous system in preclinical rodent and non-human primate models. Systemic administration of hydrophilic peptides is severely limited by enzymatic degradation in the peripheral bloodstream and poor permeability across the blood-brain barrier (BBB). Metered intranasal delivery circumvents these obstacles by utilizing direct anatomical pathways connecting the nasal mucosa to the brain parenchyma.
Preclinical tracer studies demonstrate that intranasally applied oxytocin travels along the olfactory and trigeminal nerve pathways. Passive transport occurs through perineural spaces surrounding olfactory nerve bundles that penetrate the cribriform plate into the olfactory bulb. Additionally, branches of the trigeminal nerve innervating the respiratory epithelium provide an axonal and perineural conduit to the brainstem and higher cortical structures. This bypass mechanism yields measurable peptide concentrations in the cerebrospinal fluid (CSF), amygdala, and hypothalamus without requiring invasive intracerebroventricular (ICV) cannulation.
Preclinical Literature: Social Recognition, Stress Axis Modulation, and Behavior
In vitro data and rodent models demonstrate that central oxytocin signaling modulates diverse neurobehavioral and neuroendocrine processes. In social recognition assays, administration of oxytocin into rodent test groups restored social memory deficits in knockout models, confirming the peptide's role in facilitating social habituation and recognition memory. These behavioral changes correlate with altered synaptic plasticity within the medial amygdala and nucleus accumbens.
Furthermore, preclinical literature highlights significant crosstalk between central oxytocinergic pathways and the hypothalamic-pituitary-adrenal (HPA) axis. In stress-challenge paradigms, central oxytocin signaling attenuated corticosteroid release and reduced c-Fos expression in the paraventricular nucleus (PVN) of the hypothalamus. Research examining central regulatory peptide systems often compares these neuroendocrine interactions with other peptide pathways, such as those detailed in studies on the gut-brain axis neuropeptide responses, to understand systemic homeostasis.
Comparative Analysis: Oxytocin vs. Related Neuropeptide Compounds
Oxytocin shares structural homology with arginine vasopressin (AVP), differing by only two amino acids at positions 3 (isoleucine in oxytocin vs. phenylalanine in AVP) and 8 (leucine in oxytocin vs. arginine in AVP). Despite these subtle structural variations, the two neuropeptides display distinct receptor selectivity profiles. AVP binds with high affinity to V1a, V1b, and V2 receptors, driving vasoconstriction and renal water reabsorption, whereas oxytocin exhibits primary selectivity for the OXTR with minimal cross-reactivity at physiological concentrations. Laboratories investigating vasopressinergic signaling often contrast these properties with those found in arginine vasopressin receptor assays.
Synthetic analogs have also been developed to alter half-life and receptor selectivity in research settings. For example, carbetocin incorporates a modified N-terminus and a thioether bridge replacing the disulfide bond, conferring enhanced enzymatic stability against aminopeptidases. Researchers interested in receptor kinetics and peptide stability profiles frequently benchmark standard oxytocin against synthetic variants discussed in carbetocin analog research guides.
Quality Verification Standards: RP-HPLC, Mass Spectrometry, and Endotoxin Testing
Assuring analytical purity is paramount for reproducing published experimental results. PX1 Research enforces a multi-step quality control protocol for every lot of oxytocin. Purity is characterized using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) under optimized gradient conditions, ensuring the target nonapeptide accounts for >99% of total chromatographic peak area and that truncated or oxidized species are eliminated.
Identity verification is performed via Electrospray Ionization Mass Spectrometry (ESI-MS), confirming the exact monoisotopic molecular weight (1007.19 Da). Additionally, because bacterial lipopolysaccharides (LPS) induce severe neuroinflammatory responses that confound behavioral and immunological data, all intranasal research formulations undergo chromogenic Limulus Amebocyte Lysate (LAL) assay testing. Endotoxin levels are guaranteed below stringent limits (<0.01 EU/mg), matching standards required for sensitive cell culture and animal studies. Institutional buyers managing large-scale screening projects can review bulk supply metrics through our wholesale research accounts portal.
Storage, Stability, and Handling Protocols for Research Solutions
Maintaining nonapeptide integrity requires strict adherence to temperature and handling protocols. Lyophilized oxytocin powder displays optimal long-term stability when stored at -20°C or -80°C in a desiccated environment, shielded from light. Under these conditions, the peptide backbone resists hydrolysis and oxidation for extended periods.
Once reconstituted into an intranasal liquid matrix or aqueous buffer (such as sterile 0.9% sodium chloride or phosphate-buffered saline), liquid solutions should be kept refrigerated at 2°C to 8°C and utilized within the timeframe specified by the experimental design. Exposure to ambient room temperatures, direct ultraviolet light, or repeated freeze-thaw cycles leads to disulfide bond rearrangement, peptide aggregation, and accelerated cleavage of the C-terminal amide group.
Laboratory Safety, Solubility, and Buffer Considerations
In vitro protocols involving oxytocin require careful selection of solvent matrices to preserve bioactivity without inducing cytotoxicity in cell lines. Oxytocin is highly soluble in polar aqueous solvents, including standard cell culture media, tris-buffered saline (TBS), and PBS (pH 7.4). Solubilization in dimethyl sulfoxide (DMSO) is rarely required and should be restricted to low concentrations (<0.1% v/v in final assay media) to avoid membrane destabilization.
When preparing solutions for microfluidic devices, organoid cultures, or slice physiology, researchers should utilize low-protein-binding polypropylene vessels. Standard polystyrene laboratory plastics can absorb lipophilic regions of small peptides, inadvertently reducing the effective concentration of oxytocin in low-nanomolar assay conditions. Detailed handling methods and assay integration strategies are curated in our peptide research library.
Procurement and Lot-Specific Documentation at PX1 Research
PX1 Research is dedicated to supplying the scientific community with reliable, USA-manufactured research compounds. Every unit of oxytocin nasal spray is synthesized in ISO 17025 accredited and cGMP-compliant facilities, providing complete batch-to-batch consistency for academic, biotechnology, and institutional laboratories.
Orders placed Monday through Friday ship same-day from our dual distribution centers located in California and Arizona, minimizing transit times and thermal exposure. Every shipment includes a lot-specific Certificate of Analysis (COA) detailing RP-HPLC chromatograms, mass spectra, sequence validation, and endotoxin levels. Browse our full catalog of research peptides to source fully verified compounds for your laboratory's ongoing research initiatives.
Frequently Asked Questions
What is the intended application of oxytocin nasal spray purchased from PX1 Research?
Oxytocin nasal spray provided by PX1 Research is strictly intended for in vitro laboratory assays, biochemical analysis, and preclinical animal research models. It is not approved, labeled, or supplied for human or veterinary administration, medical treatment, or therapeutic use.
How is the purity and concentration of oxytocin nasal spray verified?
Every lot undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify peptide purity (>99%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm sequence identity and molecular weight. Lot-specific COAs documenting these analytical results are provided with every order.
Why is intranasal delivery used in preclinical oxytocin research?
Intranasal delivery allows research compounds to bypass the blood-brain barrier via direct transport pathways along the olfactory and trigeminal nerves, achieving targeted central nervous system distribution in animal models without requiring invasive surgical procedures like intracerebroventricular cannulation.
What are the recommended storage conditions for oxytocin nasal spray?
Liquid intranasal research formulations should be stored refrigerated at 2°C to 8°C, protected from light and heat exposure. Freeze-thaw cycles should be avoided to prevent peptide aggregation and disulfide bond degradation.
Does oxytocin cross-react with vasopressin receptors in experimental models?
Oxytocin exhibits high selectivity for the oxytocin receptor (OXTR). While structural similarity to arginine vasopressin allows minimal cross-reactivity at high physiological or pharmacological concentrations in vitro, standard experimental concentrations demonstrate robust selective OXTR binding.
What endotoxin controls are enforced for PX1 Research oxytocin formulations?
All formulations are tested using the chromogenic Limulus Amebocyte Lysate (LAL) assay to ensure bacterial endotoxin levels remain below 0.01 EU/mg, preventing neuroinflammatory artifacts in cell cultures and preclinical animal models.
What documentation accompanies an order of oxytocin nasal spray?
Each order includes a physical or digital lot-specific Certificate of Analysis (COA) containing HPLC chromatograms, mass spectrometry spectra, purity percentages, and endotoxin clearance values.
Are bulk ordering options available for institutional research facilities?
Yes, PX1 Research provides institutional accounts and bulk purchasing programs for qualified academic laboratories, biotechnology firms, and research organizations requiring high-volume or recurring peptide supply.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.